First issue RIVM Newsletter We have launched the RIVM newsletter. We would like to keep you informed about the developments in public health and the environment in the Netherlands and our institute.
6th SAF€RA Symposium Sustainable Safety 2030 On June 14th and 15th, the 6th SAF€RA - Coordination of European Research on Industrial Safety towards Smart and Sustainable Growth - Symposium will take place in the Netherlands.
One Health European Joint Programme (EJP) Expert Meeting On the 4th and 5th of June 2018, an expert meeting was held at RIVM to redefine and prioritise the topics for One Health research and integrative activities in Europe.
Protection of Defence personnel against health risks of chromium-6 was inadequate From 1984-2006, employees of the Dutch Ministry of Defence were exposed to chromium-6 during maintenance work.
Health research in the Caribbean Netherlands: fewer smokers, more overweight One in six inhabitants of the Caribbean Netherlands is a smoker, one in eight is a heavy drinker and over six in ten are overweight. Half of the population are getting sufficient exercise.
Measures to reduce microplastic emissions in the environment Microplastics are plastic particles that are smaller than 5 millimetres; through the use of plastic or rubber products these microplastics can end up in the environment (surface water, soil, and ai
RIVM and VU investigate differences between men and women in healthy ageing Healthy ageing and being able to live an independent life until old age is not experienced by everybody.
Hans Brug new director-general RIVM Professor J. (Hans) Brug has been appointed director-general of RIVM per September 10, 2018.
Rapid developments in modern biotechnology are a challenge for risk assessment Due to developments in modern biotechnology, such as genome editing, synthetic biology and regulation of gene expression, many new applications are expected in the next ten years.
Bacteriophages: insufficient understanding of phage treatment of human infections Bacteriophages are viruses that can kill bacteria. The question is whether bacteriophages can be used to treat infections in humans.